Peripheral CB1R as a modulator of metabolic inflammation
Authors:
Open Access
- 14 March 2021
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21232
Abstract
Obesity is associated with chronic inflammation in insulin‐sensitive tissues, including liver and adipose tissue, and causes hormonal/metabolic complications, such as insulin resistance. There is growing evidence that peripheral cannabinoid‐type 1 receptor (CB1R) is a crucial participant in obesity‐induced pro‐inflammatory responses in insulin‐target tissues, and its selective targeting could be a novel therapeutic strategy to break the link between insulin resistance and metabolic inflammation. In this review, we introduce the role of peripheral CB1R in metabolic inflammation and as a mediator of hormonal/metabolic complications that underlie metabolic syndrome, including fatty liver, insulin resistance, and dyslipidemia. We also discuss the therapeutic potential of second‐ and third‐generation peripherally restricted CB1R antagonists for treating obesity‐induced metabolic inflammation without eliciting central CB1R‐mediated neurobehavioral effects, predictive of neuropsychiatric side effects, in humans.Keywords
Funding Information
- National Research Foundation of Korea (2019R1A6A1A11051471, 2019R1A2B5B03100464, 2019R1I1A1A01061122)
This publication has 96 references indexed in Scilit:
- Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and MetabolismInternational Journal of Endocrinology, 2013
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in MiceGastroenterology, 2012
- Anti‐obesity efficacy of LH‐21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet‐induced obese ratsBritish Journal of Pharmacology, 2011
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- The endocannabinoid system links gut microbiota to adipogenesisMolecular Systems Biology, 2010
- Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in miceBioorganic & Medicinal Chemistry Letters, 2009
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?Trends in Pharmacological Sciences, 2009
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Mechanisms underlying the resistance to diet-induced obesity in germ-free miceProceedings of the National Academy of Sciences, 2007
- Inflammation and metabolic disordersNature, 2006